Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO1998025628 - PHARMACEUTICAL COMPOSITIONS CONTAINING ALENDRONATE AND AN AGENT PROMOTING GASTRIC EMPTYING

Publication Number WO/1998/025628
Publication Date 18.06.1998
International Application No. PCT/US1997/022554
International Filing Date 08.12.1997
Chapter 2 Demand Filed 11.05.1998
IPC
A61K 31/66 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
66Phosphorus compounds
CPC
A61K 31/66
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
66Phosphorus compounds
A61P 3/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
12for electrolyte homeostasis
14for calcium homeostasis
Applicants
  • FUISZ TECHNOLOGIES LTD. [US]/[US]
Inventors
  • FUISZ, Richard, C.
Agents
  • NOLAN, Sandra, M.
Priority Data
08/762,67211.12.1996US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITIONS CONTAINING ALENDRONATE AND AN AGENT PROMOTING GASTRIC EMPTYING
(FR) COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ALENDRONATE ET UN AGENT FAVORISANT LA VIDANGE GASTRIQUE
Abstract
(EN) This invention encompasses a pharmaceutical composition comprising an effective amount of alendronate salt for reducing calcium loss and an effective amount of a gastric propulsive agent, preferably cisapride, to prevent gastric reflux caused by the alendronate salt.
(FR) Cette invention se rapporte à une composition pharmaceutique comprenant une quantité efficace de sel alendronate pour réduire la perte de calcium et une quantité efficace d'agent propulsif gastrique, de préférence du cisapride, afin de prévenir le reflux gastrique causé par le sel alendronate.
Related patent documents
Latest bibliographic data on file with the International Bureau